Dr. Laura Chico
Recent Articles about Alto Neuroscience Inc.
Price Target on Psychiatric Drug Biotech Boosted 200% 10/27/2025
Alto Neuroscience Inc. (ANRO:NYSE) completed a US$50 million equity raise and announced plans to accelerate development of its recently acquired asset in treatment-resistant depression, noted a Wedbush report.
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
